Bschor T, Bauer M, Adli M (2014) Chronic and Treatment Resistant Depression. Dtsch Ärztebl Int

Bschor T, Kern H, Henssler J, Baethge C (2018) Switching the Antidepressant After Nonresponse in Adults With Major Depression. J Clin Psychiatry 79(1):11–18

Article  Google Scholar 

Caetano SC, Hatch JP, Brambilla P, Sassi RB, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC (2004) Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression. Psychiatry Res Neuroimaging 132(2):141–147

Article  Google Scholar 

Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391(10128):1357–1366

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dome P, Kunovszki P, Takacs P, Feher L, Balazs T, Dede K, Mulhern-Haughey S, Barbreau S, Rihmer Z (2021) Clinical characteristics of treatment-resistant depression in adults in Hungary: Real-world evidence from a 7-year-long retrospective data analysis. PLoS ONE 16(1):e245510

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dunner DL (2001) Acute and maintenance treatment of chronic depression. J Clin Psychiatry 62(6):10–16

CAS  PubMed  Google Scholar 

Frodl T, Meisenzahl EM, Zetzsche T, Hohne T, Banac S, Schorr C, Jager M, Leinsinger G, Bottlender R, Reiser M, Moller HJ (2004) Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J Clin Psychiatry 65(4):492–499

Article  PubMed  Google Scholar 

Frodl T, Jäger M, Smajstrlova I, Born C, Bottlender R, Palladino T, Reiser M, Möller H‑J, Meisenzahl EM (2008) Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. Rev Psychiatr Neurosci 33(5)

Fu CH, Williams SC, Cleare AJ, Scott J, Mitterschiffthaler MT, Walsh ND, Donaldson C, Suckling J, Andrew C, Steiner H, Murray RM (2008) Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry 64(6):505–512

Article  PubMed  Google Scholar 

Gallo S, El-Gazzar A, Zhutovsky P, Thomas RM, Javaheripour N, Li M, Bartova L, Bathula D, Dannlowski U, Davey C, Frodl T, Gotlib I, Grimm S, Grotegerd D, Hahn T, Hamilton PJ, Harrison BJ, Jansen A, Kircher T, van Wingen G (2023) Functional connectivity signatures of major depressive disorder: machine learning analysis of two multicenter neuroimaging studies. Mol Psychiatry 28(7):3013–3022

Article  PubMed  PubMed Central  Google Scholar 

Heerlein K, Young AH, Otte C, Frodl T, Degraeve G, Hagedoorn W, Oliveira-Maia AJ, Sola PV, Rathod S, Rosso G, Sierra P, Morrens J, Van Dooren G, Gali Y, Perugi G (2021b) Real-world evidence from a European cohort study of patients with treatment resistant depression: Baseline patient characteristics. J Affect Disord 283:115–122

Article  CAS  PubMed  Google Scholar 

Hölzel L, Härter M, Reese C, Kriston L (2011) Risk factors for chronic depression—A systematic review. J Affect Disord 129(1):1–13

Article  PubMed  Google Scholar 

https://register.awmf.org/assets/guidelines/nvl-005l_S3_Unipolare_Depression_2022-10.pdf. Zugegriffen: 24. Febr. 2024

https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-investigation-medicinal-products-treatment-depression-revision-2_en.pdf. Zugegriffen: 24. Febr. 2024

Iancu SC, Wong YM, Rhebergen D, van Balkom A, Batelaan NM (2020) Long-term disability in major depressive disorder: a 6-year follow-up study. Psychol Med 50(10):1644–1652

Article  PubMed  Google Scholar 

Jacobi F, Höfler M, Strehle J et al (2014) Psychische Störungen in der Allgemeinbevölkerung: Studie zur Gesundheit Erwachsener in Deutschland und ihr Zusatzmodul Psychische Gesundheit (DEGS1-MH). Nervenarzt 85(1):77–87 (Erratum: Nervenarzt 2016; 87(1):88–90)

Article  CAS  PubMed  Google Scholar 

Jaffe DH, Rive B, Denee TR (2019) The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study. BMC Psychiatry 19(1):247

Article  PubMed  PubMed Central  Google Scholar 

Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Paulus MP, Kunovac JL, Leon AC, Mueller TI, Rice JA, Keller MB (1998b) A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 55(8):694–700

Article  CAS  PubMed  Google Scholar 

Kautzky A, Baldinger P, Souery D et al (2015) The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression. Eur Neuropsychopharmacol 25(4):441–453. https://doi.org/10.1016/j.euroneuro.2015.01.001

Article  CAS  PubMed  Google Scholar 

Keitner GI, Mansfield AK (2012) Management of Treatment-Resistant Depression. Psychiatr Clin N Am 35(1):249–265

Article  Google Scholar 

McIntyre RS, Alsuwaidan M, Baune BT, Berk M, Demyttenaere K, Goldberg JF, Gorwood P, Ho R, Kasper S, Kennedy SH, Ly-Uson J, Mansur RB, McAllister-Williams RH, Murrough JW, Nemeroff CB, Nierenberg AA, Rosenblat JD, Sanacora G, Schatzberg AF, Maj M (2023) Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. - 22(3):394–412

Mulder RT, Joyce PR, Frampton CM (2010) Personality disorders improve in patients treated for major depression. Acta Psychiatr Scand 122(3):219–225

Article  PubMed  Google Scholar 

Murphy JA, Byrne GJ (2012) Prevalence and correlates of the proposed DSM‑5 diagnosis of Chronic Depressive Disorder. J Affect Disord 139(2):172–180

Article  PubMed  Google Scholar 

Ren F, Ma Y, Zhu X, Guo R, Wang J, He L (2020) Pharmacogenetic association of bi- and triallelic polymorphisms of SLC6A4 with antidepressant response in major depressive disorder. J Affect Disord 273:254–264

Article  CAS  PubMed  Google Scholar 

Rush AJ, Sackeim HA, Conway CR, Bunker MT, Hollon SD, Demyttenaere K, Young AH, Aaronson ST, Dibué M, Thase ME, McAllister-Williams RH (2022) Clinical research challenges posed by difficult-to-treat depression. Psychol Med 52(3):419–432

Article  PubMed  PubMed Central  Google Scholar 

Seemuller F, Obermeier M, Schennach R, Bauer M, Adli M, Brieger P, Laux G, Riedel M, Falkai P, Moller HJ (2016) Stability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatients. BMC Psychiatry 16:153

Article  PubMed  PubMed Central  Google Scholar 

Solbakken OA, Abbass A (2016) Symptom- and personality disorder changes in intensive short-term dynamic residential treatment for treatment-resistant anxiety and depressive disorders. Acta Neuropsychiatr 28(5):257–271

Article  PubMed  Google Scholar 

Struck N, Krug A, Feldmann M, Yuksel D, Stein F, Schmitt S, Meller T, Brosch K, Dannlowski U, Meinert S, Opel N, Lemke H, Waltemate L, Nenadić I, Kircher T, Brakemeier E‑L (2020) Attachment and social support mediate the association between childhood maltreatment and depressive symptoms. J Affect Disord 273:310–317

Article  PubMed  Google Scholar 

van Tol MJ, van der Wee NJA, Veltman DJ (2021) Fifteen years of NESDA Neuroimaging: An overview of results related to clinical profile and bio-social risk factors of major depressive disorder and common anxiety disorders. J Affect Disord 289:31–45

Article  PubMed  Google Scholar 

Vogelbacher C, Möbius TWD, Sommer J, Schuster V, Dannlowski U, Kircher T, Dempfle A, Jansen A, Bopp MHA (2018) The Marburg-Münster Affective Disorders Cohort Study (MACS): A quality assurance protocol for MR neuroimaging data. Neuroimage 172:450–460

Article  PubMed  Google Scholar 

Williams LM, Korgaonkar MS, Song YC, Paton R, Eagles S, Goldstein-Piekarski A, Grieve SM, Harris AW, Usherwood T, Etkin A (2015) Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT‑D Trial. Neuropsychopharmacology 40(10):2398–2408

Article  CAS  PubMed  PubMed Central  Google Scholar